Exane Derivatives’s Microsoft MSFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$6.17M Sell
24,041
-3,983
-14% -$1.08M 3.55% 2
2022
Q1
$8.64M Buy
28,024
+479
+2% +$144K 2.43% 2
2021
Q4
$9.26M Sell
27,545
-9,338
-25% -$3.03M 2.24% 5
2021
Q3
$10.4M Sell
36,883
-2,335
-6% -$679K 2.5% 3
2021
Q2
$11M Buy
39,218
+2,782
+8% +$707K 2.5% 3
2021
Q1
$8.59M Buy
36,436
+2,960
+9% +$687K 2.46% 3
2020
Q4
$7.45M Buy
33,476
+745
+2% +$160K 2.19% 2
2020
Q3
$6.88M Sell
32,731
-3,848
-11% -$808K 1.99% 10
2020
Q2
$7.44M Buy
36,579
+7,912
+28% +$1.44M 1.99% 8
2020
Q1
$4.52M Buy
28,667
+3,878
+16% +$638K 1.26% 19
2019
Q4
$4.04M Buy
24,789
+8,260
+50% +$1.21M 0.75% 33
2019
Q3
$2.3M Buy
16,529
+2,445
+17% +$336K 0.41% 62
2019
Q2
$1.89M Buy
+14,084
New +$1.79M 0.33% 73
2019
Q1
Sell
-5,839
Closed -$593K 697
2018
Q4
$593K Buy
+5,839
New +$625K 0.11% 164
2017
Q1
Sell
-3,487
Closed -$217K 626
2016
Q4
$217K Sell
3,487
-8,120
-70% -$488K 0.04% 200
2016
Q3
$669K Sell
11,607
-17,639
-60% -$996K 0.1% 136
2016
Q2
$1.5M Buy
29,246
+17,773
+155% +$924K 0.25% 62
2016
Q1
$634K Buy
11,473
+1,605
+16% +$84.1K 0.08% 120
2015
Q4
$547K Buy
9,868
+4,237
+75% +$223K 0.08% 111
2015
Q3
$249K Sell
5,631
-27,633
-83% -$1.24M 0.03% 171
2015
Q2
$1.47M Sell
33,264
-15,968
-32% -$729K 0.16% 73
2015
Q1
$2M Buy
49,232
+19,075
+63% +$830K 0.22% 61
2014
Q4
$1.4M Buy
+30,157
New +$1.42M 0.19% 85

Other funds holding MSFT

Exane Derivatives's MSFT Position: Q2 2022 in Review

Exane Derivatives reduced its Microsoft (MSFT) stake by 14% in Q2 2022, selling an estimated $1.08M and leaving 24,041 shares worth $6.17M. The position accounts for 3.55% of the portfolio, ranked #2.

Exane Derivatives first reported a position in MSFT in Q4 2014 and has held it in 23 quarters since. The position peaked at $11M in Q2 2021. 4,508 funds tracked by Wall St. Rank hold MSFT as of Q2 2022.

  • Exane Derivatives held 24,041 shares of Microsoft worth $6.17M as of Q2 2022.
  • Exane Derivatives sold 3,983 Microsoft shares in Q2 2022, an estimated $1.08M.
  • Microsoft made up 3.55% of Exane Derivatives's portfolio in Q2 2022, its #2 holding.
  • Exane Derivatives first reported a position in Microsoft in Q4 2014 and has held it in 23 quarters since.
  • Exane Derivatives's Microsoft position peaked at $11M in Q2 2021.
  • 4,508 funds tracked by Wall St. Rank held Microsoft as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.